Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

AVARA Rx vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.5

AVARA Rx

Best for Buyers who value supply-chain transparency and want a 50-state-confirmed cash-pay compounded GLP-1 platform with both named pharmacy (DiRx Health) and named clinical network (Beluga Health) disclosed. Strong fit for buyers comfortable with mid-tier pricing ($229 sema / $279 tirz) in exchange for the named-partner disclosure, and who want optional brand Wegovy/Zepbound/Foundayo consultations within the same platform. NOT the cheapest Beluga-network option — buyers focused on lowest cost should compare against Trimi ($99/mo sema), Coby Health ($99/mo sema), or Nalena ($149/mo). NOT for buyers needing insurance, dose-ladder transparency before purchase, or a named medical director.
★★★☆☆3.3

Starting at $229/mo

Compounded Semaglutide injection — starting $229/mo (Personalized GLP-1)Compounded Tirzepatide injection — starting $279/mo (Personalized GLP-1/GIP)Brand Wegovy® injection + Wegovy® Pill consultations availableBrand Zepbound® + Foundayo® consultations available
Visit AVARA Rx
8.7

Vytora Health

Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
★★★★4.4

Starting at $150/mo

CompoundedBrand-Name Available (Mounjaro + Zepbound)All 50 States + DCLegitScript Approved
Visit Vytora Health

Side-by-Side Comparison

FeatureAVARA RxVytora Health
Overall Score6.5/108.7/10
Starting Price$229/mo$150/mo
Editorial Rating3.3 ★ /54.4 ★ /5
Features12 features10 features
States Available5051
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

AVARA Rx

Pros

  • Explicit named pharmacy partner disclosure — DiRx Health, 3540 NW 56th St STE 204, Ft Lauderdale FL 33309. Buyers can independently verify DiRx's licensure. Significantly above the 'licensed third-party pharmacy' generic-language floor common to DTC compounded platforms.
  • Explicit named clinical network disclosure — Beluga Health (belugahealth.com), the same physician-led virtual care platform used by Trimi, Healthicare, Nalena, PauseRX, Trava, and Coby Health. Buyers can research the clinical platform handling their prescriptions.
  • All 50 states explicitly enumerated on the FAQ — uncommon transparency vs DTC peers that say 'nationwide' without a state list
  • Refund policy is patient-friendly: full refund if provider disqualifies, partial refund if a weaker dose is prescribed
  • LegitScript verification badge displayed on homepage (claimed; independent merchant-ID lookup pending)
  • Pharmacy claimed to use NABP-accredited facilities (per FAQ)
  • Brand drug consultations (Wegovy, Wegovy Pill, Zepbound, Foundayo) available alongside compounded options — buyers can pivot between compounded and brand without switching platforms
  • Adjunct HRT + TRT + longevity stack (Sermorelin, NAD+, Glutathione) — broader wellness platform vs single-product GLP-1 storefronts

Cons

  • Operating legal entity name NOT disclosed verbatim — only 'AVARA Rx' surfaced; no LLC or corp suffix on the homepage, FAQ, or contact page. Mailing address is a Sheridan, WY registered-agent-style address (30 N Gould Street Suite R), which is a common Wyoming registered-agent shell address — does not by itself reveal the operating entity
  • Pricing dose ladder NOT itemized — only 'starting at $229' (sema) and 'starting at $279' (tirz) surfaced. No per-strength pricing for 0.25mg/0.5mg/1mg/1.7mg/2.4mg sema or 2.5mg/5mg/7.5mg/10mg/12.5mg/15mg tirz
  • LegitScript ID number NOT specified on the homepage — badge is displayed but the verifiable certification number is not surfaced, preventing direct merchant-ID lookup
  • Named medical director / clinical lead NOT disclosed by name (Beluga Health is the network, not a named MD)
  • Lab work requirements NOT specified in the FAQ — unclear whether baseline labs are required, recommended, or optional
  • Consultation fee structure NOT disclosed separately from medication cost
  • Insurance NOT accepted — cash-pay only
  • HSA/FSA eligibility NOT confirmed in FAQ
  • Pricing is mid-tier ($229 sema / $279 tirz) vs the LOW end of the DTC compounded market (Trimi $99/$125, Coby $99/$179) — buyers paying for the Beluga + DiRx transparency premium vs lower-priced Beluga-network peers
  • Same Beluga-clinical-network risk profile as Trimi, Healthicare, Nalena, PauseRX, Trava, Coby — if Beluga Health faces regulatory action, multiple WLR-listed platforms (including AVARA Rx) would be simultaneously affected

Vytora Health

Pros

  • All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
  • Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
  • LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
  • Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
  • Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
  • Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
  • Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens

Cons

  • Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
  • Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
  • Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
  • Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
  • Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)

Our Verdict

Winner: Vytora HealthScore: 8.7/10

Vytora Health edges out AVARA Rx with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. AVARA Rx remains a solid alternative, especially if you're looking for Buyers who value supply-chain transparency and want a 50-state-confirmed cash-pay compounded GLP-1 platform with both named pharmacy (DiRx Health) and named clinical network (Beluga Health) disclosed. Strong fit for buyers comfortable with mid-tier pricing ($229 sema / $279 tirz) in exchange for the named-partner disclosure, and who want optional brand Wegovy/Zepbound/Foundayo consultations within the same platform. NOT the cheapest Beluga-network option — buyers focused on lowest cost should compare against Trimi ($99/mo sema), Coby Health ($99/mo sema), or Nalena ($149/mo). NOT for buyers needing insurance, dose-ladder transparency before purchase, or a named medical director..

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring AVARA Rx and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.